Literature DB >> 8896994

Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients.

L M Galanti1, J Jamart, J Dell'omo, J Donckier.   

Abstract

Small amounts of urinary proteins observed at early stages of diabetic nephropathy may result from both glomerular and proximal tubular dysfunction. However, the relative contribution of the two mechanisms remains controversial. We compared the urinary excretion of three low-molecular-weight proteins (albumin, alpha 1-microglobulin and retinal-binding protein) in 104 diabetic patients and 104 control subjects who had a plasma creatinine concentration of less than 130 mumol/l. Excretion of low-molecular-weight proteins was expressed as the ratio of protein to creatinine concentration. There were significant correlation (p < 0.01) between excretion of the three low-molecular-weight proteins measured in urine sample and 24-h urine collections in diabetic and control subjects. The concentrations of these proteins in single voided urinary samples and 24-h urine collections in diabetic patients were highly correlated. Excretion of retinal-binding protein, alpha 1-microglobulin and glucose in 24-h urine collections and of RBP and glucose in urinary samples was higher in diabetic than non-diabetic patients regardless of the type of diabetes and insulin-dependence. alpha 1-microglobulin and albumin excretions in urinary samples were significantly influenced by blood glucose control, as attested by the glycosylated haemoglobin level. Increased urinary excretion of alpha 1-microglobulin and retinol-binding protein reflected proximal tubular dysfunction in diabetic patients. However, only alpha 1-microglobulin correlated with the glycaemic control. It remains to be determined whether this protein could serve as an additional early marker of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896994

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  7 in total

1.  Urine AQP5 is a potential novel biomarker of diabetic nephropathy.

Authors:  Yiyang Lu; Lihe Chen; Binhong Zhao; Zhou Xiao; Ting Meng; Qiaoling Zhou; Wenzheng Zhang
Journal:  J Diabetes Complications       Date:  2016-03-29       Impact factor: 2.852

2.  Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice.

Authors:  Nimesh Mody; Timothy E Graham; Yuki Tsuji; Qin Yang; Barbara B Kahn
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-19       Impact factor: 4.310

3.  Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes.

Authors:  David A Brott; Stephen T Furlong; Scott H Adler; James W Hainer; Ramin B Arani; Mark Pinches; Peter Rossing; Nish Chaturvedi
Journal:  Drug Des Devel Ther       Date:  2015-06-22       Impact factor: 4.162

4.  Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.

Authors:  Mohamed H Mahfouz; Adel M Assiri; Mohammed H Mukhtar
Journal:  Biomark Insights       Date:  2016-02-16

5.  Soybeans ameliolate diabetic nephropathy in rats.

Authors:  Young Eun Choi; Soo Kyung Ahn; Won Taek Lee; Jong Eun Lee; Seung Hwa Park; Bang Bu Yoon; Kyung Ah Park
Journal:  Evid Based Complement Alternat Med       Date:  2008-03-20       Impact factor: 2.629

6.  Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.

Authors:  Kentaro Inoue; Jun Wada; Jun Eguchi; Atsuko Nakatsuka; Sanae Teshigawara; Kazutoshi Murakami; Daisuke Ogawa; Takahiro Terami; Akihiro Katayama; Atsuhito Tone; Izumi Iseda; Kazuyuki Hida; Masao Yamada; Tomohisa Ogawa; Hirofumi Makino
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

7.  Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis.

Authors:  Yongzhang Qin; Shuang Zhang; Xiaofang Shen; Shunming Zhang; Jingyu Wang; Minxia Zuo; Xiao Cui; Zhongai Gao; Juhong Yang; Hong Zhu; Baocheng Chang
Journal:  Ther Adv Endocrinol Metab       Date:  2019-12-02       Impact factor: 3.565

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.